Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 02-Jul-20 4:28 PM View:  | Glowpoint, Inc. (OBLG) | 04-Jun-20 | Grant | 11,667 | $1.07 | $12,483.70 | 28% 41.27K to 52.93K | |
| 02-Jul-20 4:28 PM View: | Glowpoint, Inc. (OBLG) | 04-Jun-20 | Payment of Exercise | 3,999 | $1.07 | $4,278.93 | (8%) 52.93K to 48.93K | |
| 02-Jul-20 4:28 PM View: | Glowpoint, Inc. (OBLG) | 13-Apr-20 | Payment of Exercise | 3,999 | $1.10 | $4,398.90 | (9%) 45.26K to 41.27K | |
| 06-May-19 4:08 PM View: | Glowpoint, Inc. (OBLG) | 02-May-19 | Grant | 22,334 | $1.46 | $32,607.60 | 74% 30.22K to 52.55K | 8% |
| 06-May-19 4:08 PM View: | Glowpoint, Inc. (OBLG) | 02-May-19 | Payment of Exercise | 3,936 | $1.46 | $5,746.56 | (7%) 52.55K to 48.61K | (8%) |
| 03-Jul-18 4:04 PM View: | Glowpoint, Inc. (OBLG) | 01-Jul-18 | Payment of Exercise | 20,568 | $0.20 | $4,113.60 | (6%) 322.73K to 302.16K | |
| 16-Apr-18 4:06 PM View: | Glowpoint, Inc. (OBLG) | 13-Apr-18 | Grant | 116,667 | $0.21 | $24,500.10 | 57% 206.06K to 322.73K | |
| 15-Mar-18 5:50 PM View: | Glowpoint, Inc. (OBLG) | 14-Mar-18 | Payment of Exercise | 29,569 | $0.25 | $7,392.25 | (13%) 235.63K to 206.06K | (8%) |
| 28-Mar-16 4:37 PM View: | Glowpoint, Inc. (OBLG) | 25-Mar-16 | Payment of Exercise | 9,320 | $0.42 | $3,914.40 | (4%) 244.95K to 235.63K | 37% |
| 28-Jan-16 5:57 PM View: | Glowpoint, Inc. (OBLG) | 26-Jan-16 | Grant | 61,257 | -- | -- | 33% 183.69K to 244.95K | |
| 26-Mar-15 4:02 PM View: | Glowpoint, Inc. (OBLG) | 25-Mar-15 | Payment of Exercise | 7,723 | $0.99 | $7,645.77 | (4%) 191.41K to 183.69K | 73% |
| 10-Mar-15 4:02 PM View: | Glowpoint, Inc. (OBLG) | 07-Mar-15 | Payment of Exercise | 13,093 | $0.93 | $12,176.50 | (6%) 204.51K to 191.41K | 66% |
| 06-Feb-15 4:31 PM View: | Glowpoint, Inc. (OBLG) | 04-Feb-15 | Grant | 80,000 | $1.04 | $83,200.00 | 64% 124.51K to 204.51K | (74%) |
| 27-May-14 4:00 PM View: | Glowpoint, Inc. (OBLG) | 25-May-14 | Payment of Exercise | 647 | $1.60 | $1,035.20 | (< 1%) 125.15K to 124.51K | 83% |
| 28-Apr-14 4:03 PM View: | Glowpoint, Inc. (OBLG) | 25-Apr-14 | Payment of Exercise | 648 | $1.53 | $991.44 | (< 1%) 125.8K to 125.15K | 83% |
| 26-Mar-14 4:01 PM View: | Glowpoint, Inc. (OBLG) | 25-Mar-14 | Payment of Exercise | 9,320 | $1.81 | $16,869.20 | (7%) 135.12K to 125.8K | 85% |
| 11-Mar-14 4:01 PM View: | Glowpoint, Inc. (OBLG) | 07-Mar-14 | Grant | 35,121 | -- | -- | 35% 100.0K to 135.12K | |
| 27-Mar-13 4:15 PM View: | Glowpoint, Inc. (OBLG) | 25-Mar-13 | Grant | 100,000 | -- | -- | 100% 0 to 100.0K | |
| 05-Sep-12 4:44 PM View: | Allos Therapeutics, Inc. (ALTH) | 04-Sep-12 | Disposition (change in control) | 207,114 | $1.82 | $376,948.00 | (100%) 207.11K to 0 | (< 1%) |
| 01-Mar-12 6:15 PM View: | Allos Therapeutics, Inc. (ALTH) | 01-Mar-12 | Market Sale (Planned) | 3,385 | $1.50 | $5,073.44 | (2%) 210.5K to 207.11K | 3% |
| 01-Mar-12 6:15 PM View: | Allos Therapeutics, Inc. (ALTH) | 29-Feb-12 | Market Sale (Planned) | 3,388 | $1.52 | $5,164.67 | (2%) 213.89K to 210.5K | 4% |
| 01-Mar-12 6:15 PM View: | Allos Therapeutics, Inc. (ALTH) | 28-Feb-12 | Grant | 99,779 | -- | -- | 87% 114.11K to 213.89K | |
| 27-Feb-12 5:42 PM View: | Allos Therapeutics, Inc. (ALTH) | 24-Feb-12 | Market Sale (Planned) | 595 | $1.55 | $922.31 | (< 1%) 114.7K to 114.11K | (2%) |
| 27-Feb-12 5:42 PM View: | Allos Therapeutics, Inc. (ALTH) | 23-Feb-12 | Market Sale (Planned) | 1,460 | $1.57 | $2,290.59 | (1%) 116.16K to 114.7K | (< 1%) |
| 17-Nov-11 5:08 PM View: | Allos Therapeutics, Inc. (ALTH) | 16-Nov-11 | Market Sale (Planned) | 125 | $1.43 | $178.75 | (< 1%) 116.29K to 116.16K | |
| 17-Nov-11 5:08 PM View: | Allos Therapeutics, Inc. (ALTH) | 15-Nov-11 | Market Sale (Planned) | 5,438 | $1.45 | $7,860.63 | (4%) 121.73K to 116.29K | |
| 02-Mar-11 5:06 PM View: | Allos Therapeutics, Inc. (ALTH) | 28-Feb-11 | Grant | 53,957 | -- | -- | 80% 67.77K to 121.73K | |
| 25-Feb-11 5:28 PM View: | Allos Therapeutics, Inc. (ALTH) | 24-Feb-11 | Market Sale (Planned) | 557 | $3.12 | $1,739.79 | (< 1%) 68.33K to 67.77K | (3%) |
| 25-Feb-11 5:28 PM View: | Allos Therapeutics, Inc. (ALTH) | 23-Feb-11 | Market Sale (Planned) | 1,365 | $3.25 | $4,439.12 | (2%) 69.69K to 68.33K | 1% |
| 22-Oct-10 5:13 PM View: | Allos Therapeutics, Inc. (ALTH) | 20-Oct-10 | Grant | 50,336 | -- | -- | 260% 19.36K to 69.69K | |
| 12-May-10 5:53 PM View: | Allos Therapeutics, Inc. (ALTH) | 10-May-10 | Option Exercise | 3,085 | $2.87 | $8,847.23 | 16% 19.36K to 22.44K | |
| 12-May-10 5:53 PM View: | Allos Therapeutics, Inc. (ALTH) | 10-May-10 | Market Option Sale (Planned) | 3,085 | $7.03 | $21,684.50 | (14%) 22.44K to 19.36K | (3%) |
| 12-Mar-10 6:39 PM View: | Allos Therapeutics, Inc. (ALTH) | 10-Mar-10 | Option Exercise | 20,000 | $4.78 | $95,600.00 | 103% 19.36K to 39.35K | |
| 12-Mar-10 6:39 PM View: | Allos Therapeutics, Inc. (ALTH) | 10-Mar-10 | Market Option Sale (Planned) | 20,000 | $7.78 | $155,612.00 | (51%) 39.35K to 19.36K | (2%) |
| 08-Mar-10 6:06 PM View: | Allos Therapeutics, Inc. (ALTH) | 05-Mar-10 | Option Exercise | 10,000 | $2.93 | $29,300.00 | 52% 19.36K to 29.36K | |
| 08-Mar-10 6:06 PM View: | Allos Therapeutics, Inc. (ALTH) | 05-Mar-10 | Market Option Sale (Planned) | 7,275 | $7.02 | $51,067.60 | (25%) 29.36K to 22.08K | (4%) |
| 08-Mar-10 6:06 PM View: | Allos Therapeutics, Inc. (ALTH) | 05-Mar-10 | Market Sale (Planned) | 2,725 | $7.02 | $19,128.40 | (12%) 22.08K to 19.36K | (4%) |
| 08-Mar-10 6:06 PM View: | Allos Therapeutics, Inc. (ALTH) | 04-Mar-10 | Option Exercise | 8,915 | $2.72 | $24,204.40 | 40% 22.08K to 31.0K | |
| 08-Mar-10 6:06 PM View: | Allos Therapeutics, Inc. (ALTH) | 04-Mar-10 | Market Option Sale (Planned) | 11,640 | $6.98 | $81,300.70 | (38%) 31.0K to 19.36K | (5%) |
| 24-Feb-10 6:07 PM View: | Allos Therapeutics, Inc. (ALTH) | 22-Feb-10 | Grant | 14,948 | -- | -- | 210% 7.13K to 22.08K | |
| 16-Mar-09 6:26 PM View: | Allos Therapeutics, Inc. (ALTH) | 13-Mar-09 | Option Exercise | 5,027 | $2.93 | $14,729.10 | 70% 7.13K to 12.16K | 132% |
| 16-Mar-09 6:26 PM View: | Allos Therapeutics, Inc. (ALTH) | 13-Mar-09 | Market Option Sale (Planned) | 5,027 | $7.00 | $35,189.00 | (41%) 12.16K to 7.13K | (11%) |
| 16-Mar-09 6:26 PM View: | Allos Therapeutics, Inc. (ALTH) | 12-Mar-09 | Option Exercise | 64,973 | $2.61 | $169,729.00 | 911% 7.13K to 72.11K | 161% |
| 16-Mar-09 6:26 PM View: | Allos Therapeutics, Inc. (ALTH) | 12-Mar-09 | Market Option Sale (Planned) | 64,973 | $7.02 | $455,812.00 | (90%) 72.11K to 7.13K | (11%) |
| 25-Feb-09 7:45 PM View: | Allos Therapeutics, Inc. (ALTH) | 23-Feb-09 | Grant | 5,875 | -- | -- | 467% 1.26K to 7.13K | |
| 05-Jul-05 1:08 PM View: | Allos Therapeutics, Inc. (ALTH) | 30-Jun-05 | Private Purchase | 272 | $1.85 | $504.02 | 28% 0.98K to 1.26K | |
| 04-Jan-05 6:10 PM View: | Allos Therapeutics, Inc. (ALTH) | 31-Dec-04 | Private Purchase | 985 | $1.85 | $1,825.21 | 100% 0 to 0.98K |